Blog
Should You Invest in the Invesco Dorsey Wright Technology Momentum ETF (PTF)?
Looking for broad exposure to the Technology - Broad segment of the equity market? You should consider the Invesco Dorsey Wright Technology Momentum ETF (PTF), a passively managed exchange traded
Is Franklin U.S. Large Cap Multifactor Index ETF (FLQL) a Strong ETF Right Now?
A smart beta exchange traded fund, the Franklin U.S. Large Cap Multifactor Index ETF (FLQL) debuted on 04/26/2017, and offers broad exposure to the Style Box - Large Cap Blend category of the
Should Invesco S&P 500 Low Volatility ETF (SPLV) Be on Your Investing Radar?
Designed to provide broad exposure to the Large Cap Blend segment of the US equity market, the Invesco S&P 500 Low Volatility ETF (SPLV) is a passively managed exchange traded fund launched on May
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
The iShares U.S. Healthcare ETF (IYH) was launched on June 12, 2000, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity
Less-Than-Expected Inflation in July: Growth ETFs to Gain?
The Consumer Price Index (CPI) increased 0.2% sequentially and 2.7% year over year, according to the Bureau of Labor Statistics (BLS). This compares with Dow Jones forecasts of 0.2% monthly and 2.8%
New Strong Buy Stocks for August 13th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
CF Bankshares Inc. CFBK: This bank holding company for CFBank has seen the Zacks Consensus Estimate for its current year
New Strong Sell Stocks for August 13th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Ascend Wellness Holdings, Inc. AAWH is a cannabis consumer packaged goods company. The Zacks Consensus Estimate for its
Best Growth Stocks to Buy for August 13th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 13th:
Pan American Silver Corp. PAAS: This mining company carries a Zacks Rank #1, and
Pathward Financial (CASH) Surpasses Q3 Earnings and Revenue Estimates (Revised)
Pathward Financial (CASH) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.57 per share. This compares to earnings of $1.66 per share a year ago. These
Best Value Stocks to Buy for August 13th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, August 13th:
Jabil Inc. JBL: This company which provides manufacturing services and solutions
Company News for Aug 13, 2025
- Cardinal Health Inc.’s (CAH) shares tumbled 7.2% after reporting fourth-quarter fiscal 2025 revenues of $60,159 million, missing the Zacks Consensus Estimate of $60,668.31 million.
- Shares of Sea
Bull of the Day: AppLovin (APP)
AppLovin (APP) is a name I’ve been following since it was just a fraction of its current size, and it has only grown more compelling as an investment opportunity. The company has carved out a
Bear of the Day: Carter's (CRI)
When it comes to identifying potential short candidates or stocks to steer clear of, apparel brands are often high on my list. The industry is notoriously difficult, as consumer trends shift
Stock Market News for Aug 13, 2025
Wall Street closed sharply higher on Tuesday following a less-than-expected inflation rate for July. Market participants are overwhelmingly hopeful for the first interest rate cut in September
Best Income Stocks to Buy for August 13th
Here are three stocks with buy rank and strong income characteristics for investors to consider today, August 13th:
National Grid plc NGG: This company that engages in the transmission and
KinderCare Learning Companies, Inc. (KLC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
KinderCare Learning Companies, Inc. (KLC) reported $700.11 million in revenue for the quarter ended June 2025, representing no change year over year. EPS of $0.22 for the same period compares to $0
Meritage Hospitality Group Inc. (MHGU) Reports Q2 Loss, Lags Revenue Estimates
Meritage Hospitality Group Inc. (MHGU) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of $0.54. This compares to earnings of $0.33 per share a year ago. These
Compared to Estimates, TWFG, Inc. (TWFG) Q2 Earnings: A Look at Key Metrics
TWFG, Inc. (TWFG) reported $60.31 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 13.2%. EPS of $0.20 for the same period compares to $14.89 a year ago.
Compared to Estimates, H&R Block (HRB) Q4 Earnings: A Look at Key Metrics
H&R Block (HRB) reported $1.11 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 4.6%. EPS of $2.27 for the same period compares to $1.89 a year ago.
The
TWFG, Inc. (TWFG) Q2 Earnings Surpass Estimates
TWFG, Inc. (TWFG) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $14.89 per share a year ago. These figures
Gladstone Investment (GAIN) Reports Q1 Earnings: What Key Metrics Have to Say
For the quarter ended June 2025, Gladstone Investment (GAIN) reported revenue of $23.54 million, up 6.2% over the same period last year. EPS came in at $0.24, compared to $0.24 in the year-ago
Compared to Estimates, Cava (CAVA) Q2 Earnings: A Look at Key Metrics
Cava Group (CAVA) reported $280.62 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 20.2%. EPS of $0.16 for the same period compares to $0.17 a year ago.
Compared to Estimates, CAE (CAE) Q1 Earnings: A Look at Key Metrics
For the quarter ended June 2025, CAE (CAE) reported revenue of $793.98 million, up 1.3% over the same period last year. EPS came in at $0.15, compared to $0.15 in the year-ago quarter.
The reported
Knightscope, Inc. (KSCP) Reports Q2 Loss, Lags Revenue Estimates
Knightscope, Inc. (KSCP) came out with a quarterly loss of $0.9 per share versus the Zacks Consensus Estimate of a loss of $1.09. This compares to a loss of $2.5 per share a year ago. These figures
Xenetic Biosciences (XBIO) Reports Q2 Loss, Misses Revenue Estimates
Xenetic Biosciences (XBIO) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.64. This compares to a loss of $0.83 per share a year ago. These


